Companies · Other Health Care

True Level Investments, Inc.

Riverside · Other Health Care

Diligence memoA one-page analyst read on True Level Investments, Inc. — recommendation, valuation, rhythm, risks.
$14.7M
Total raised · real
5
Rounds
35.7×
Latest step-up
Top 21%
Sector rank · raised
Series A
Latest stage · inferred · Thu Mar 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

True Level Investments, Inc. looks fair against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.73× the median modeled value of Series A Other Health Care companies in 2022–2024 (196 peers) — value vs value, same stage and era.
  • Within the normal band (73% of peer median) for its niche.
At-risk
  • Last raise 2.3 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

True Level Investments, Inc. is one of 5377 Other Health Care companies tracked from Riverside. By capital raised it ranks in the upper tier (ahead of 80% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2019
Year incorporated
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MSeries A · 2020-07-15 Raised $5.0M (real) Modeled valuation $100M (est)Series A2020Series A · 2021-07-22 Raised $2.0M (real) Modeled valuation $28M (est)Series A2021Series A · 2022-04-08 Raised $2.0M (real) Modeled valuation $21M (est)Series A2022Series A · 2022-11-10 Raised $4.5M (real) Modeled valuation $39M (est)Series A2022Series A · 2022-11-16 Raised $740K (real) Modeled valuation $6.4M (est)Series A2022Pre-Seed · 2022-11-16 Raised $140K (real) Modeled valuation $1.3M (est)Pre-Seed2022Series A · 2024-03-21 Raised $5.0M (real) Modeled valuation $27M (est)Series A2024+$2.0M+$2.0M+$4.5M+$740K+$140K+$5.0MCumulative $19M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$5.0M · 2020
Series A extension$2.0M · 2021
Series A extension$2.0M · 2022
Series A extension$4.5M · 2022
Series A extension$740K · 2022
Bridge · Series A-stage$140K · 2022smaller follow-on
Series A extension$5.0M · 2024

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$26.6M
Base estimate est.
$6.4M
Conservative case
$61.4M
Upside case
$22.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series A · modeled $99.6M · 2020-07-152020Series A · modeled $27.6M · 2021-07-22Series A · modeled $21.4M · 2022-04-08Series A · modeled $39.0M · 2022-11-10Series A · modeled $6.4M · 2022-11-16Pre-Seed · modeled $1.3M · 2022-11-16Series A · modeled $26.6M · 2024-03-212024
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
2.3 yr
Elapsed time used
2.3 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
7 mo
Avg between rounds
$4.0M/yr
Capital velocity
6.0 yr
On record since
2020
First round
7
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 6.1× above median
This company$14.7M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.9× of median
This company$5.0M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 1.2× above median
This company$26.6M
Sector median$22.1M

Raised more than 80% of sector peers (real $). Modeled value above 55% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #128 of 196.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)CareHarmony, Inc. · Series A Raised $17.4M · modeled $145.2M (est)Dragonfly Endoscopy Inc. · Series A Raised $12.7M · modeled $142.0M (est)NuvoAir Holdings, Inc. · Series A Raised $10.7M · modeled $125.1M (est)Post Acute Recovery, Inc. · Series A Raised $14.5M · modeled $123.0M (est)Micro Interventional Devices, Inc. · Series A Raised $14.0M · modeled $119.0M (est)Etiometry Inc. · Series A Raised $15.6M · modeled $114.7M (est)SafKan, Inc. · Series A Raised $13.0M · modeled $108.5M (est)BehaVR Holdings, Inc. · Series A Raised $12.1M · modeled $102.1M (est)Outliers Inc. · Series A Raised $13.6M · modeled $101.7M (est)RevMedica, Inc. · Series A Raised $14.2M · modeled $101.2M (est)Innovoyce LLC · Series A Raised $9.9M · modeled $97.6M (est)Prixz, Inc. · Series A Raised $9.2M · modeled $97.4M (est)True Level Investments, Inc. (this company) Raised $14.7M · modeled $26.6M (est)True Level Investments, Inc.
CompanyStageRaised · realValue · estvs peer med.
CareHarmony, Inc.Series A$17.4M$145.2M3.96×
Dragonfly Endoscopy Inc.Series A$12.7M$142.0M3.87×
NuvoAir Holdings, Inc.Series A$10.7M$125.1M3.41×
Post Acute Recovery, Inc.Series A$14.5M$123.0M3.35×
Micro Interventional Devices, Inc.Series A$14.0M$119.0M3.25×
Etiometry Inc.Series A$15.6M$114.7M3.13×
SafKan, Inc.Series A$13.0M$108.5M2.96×
BehaVR Holdings, Inc.Series A$12.1M$102.1M2.78×
Outliers Inc.Series A$13.6M$101.7M2.77×
RevMedica, Inc.Series A$14.2M$101.2M2.76×
Innovoyce LLCSeries A$9.9M$97.6M2.66×
Prixz, Inc.Series A$9.2M$97.4M2.66×
True Level Investments, Inc. this companySeries A$14.7M$26.6M0.73×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$5.0M2020-07-15$22.7M$99.6M90%
Series A$2.0M2021-07-22$9.1M$27.6M90%
Series A$2.0M2022-04-08$9.1M$21.4M90%
Series A$4.5M2022-11-10$20.5M$39.0M90%
Series A$740K2022-11-16$3.4M$6.4M90%
Pre-Seed$140K2022-11-16$778K$1.3M90%
Series A$5.0M2024-03-21$22.7M$26.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$5.0M2020-07-15
    • First recorded raise — entered as Series A.
  2. Series A$2.0M2021-07-22
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 2.5× smaller than the prior — bridge or down round.
    • Revenue band moved No revenue → $0–$1M.
  3. Series A$2.0M2022-04-08
    • Raised 9 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
    • Revenue band moved $0–$1M → $5M–$25M.
  4. Series A$4.5M2022-11-10
    • Came back fast: 7 mo vs the ~14 mo sector norm.
    • Round 2.3× larger than the prior — scaling up.
  5. Series A$740K2022-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 6.1× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  6. Pre-Seed$140K2022-11-16
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 5.3× smaller than the prior — bridge or down round.
  7. Series A$5.0M2024-03-21
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round 35.7× larger than the prior — scaling up.
Intelligence
2024 ~Q4
Modeled next raise · ~7mo cadence
$15.0M
Modeled next size est.range $9.8M$24.0M
35.7×
Last step-up
$4.0M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
ANDREW JONES5 other2021-07
Michael Patton2 other2024-03
Andrew A. Jones2022-11
Darren A. Lea2022-11
Darren Lea2024-03
Jordan A. Starke2022-11
Jordan Starke2020-07
Michael A. Patton2022-11
Nakia Richmond2024-03
Nick A. Richmond2022-11
Tony Patton2020-07
Registry & provenance

True Level Investments, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1817600
SEC CIK
2019
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Better Management Holdings, LLCOther Health CareSeries A$15.0M$22.9Msame sector · same stage
OneDirect Health Network, Inc.Other Health CareSeries A$15.0M$23.5Msame sector · same stage
Common Sensing Inc.Other Health CareSeries A$14.4M$25.7Msame sector · same stage
MyNexus, Inc.Other Health CareSeries A$15.1M$30.2Msame sector · same stage
New Century Hospice, Inc.Other Health CareSeries A$14.3M$26.2Msame sector · same stage
Wdt Acquisition CorpOther Health CareSeries A$15.3M$30.3Msame sector · same stage
Ella Health, Inc.Other Health CareSeries A$14.0M$30.3Msame sector · same stage
Independa, Inc.Other Health CareSeries A$13.6M$28.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
True Medicine Inc.Other Health CareSeries B$175.9M87%
Double Anchor Investors, LLCOther Health CarePre-Seed$13.2M85%
MidlevelU, Inc.Other Health CareSeed$16.0M84%
True North Contract Research, Inc.Other Health CareSeed$14.5M83%
CRES Holdings, Inc.Other Health CareSeries C$67.0M83%
Fullfill, Inc.Other Health CareSeries A$73.3M83%
V Shareholder Investments INc.Other Health CarePre-Seed$5.3M83%
DBN BCS II Investments, LLCOther Health CareSeed$34.0M83%
Frequently asked
How much funding has True Level Investments, Inc. raised?
True Level Investments, Inc. has raised approximately $14.7M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is True Level Investments, Inc.'s estimated valuation?
Provath's modeled valuation for True Level Investments, Inc. is approximately $26.6M (modeled range $6.4M–$61.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is True Level Investments, Inc. at?
True Level Investments, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Thu Mar 21.
What does True Level Investments, Inc. do and where is it based?
True Level Investments, Inc. operates in the Other Health Care sector, based in Riverside.
Explore related

See where True Level Investments, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at True Level Investments, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.